Dark Blue Therapeutics

About Dark Blue Therapeutics

Dark Blue Therapeutics is a biotech company focused on precision oncology, developing next-generation cancer therapies. It collaborates with leading academic experts to identify novel cancer dependencies and applies cutting-edge discovery science to create targeted, transformational medicines for patients with high unmet needs. The company emphasizes a pipeline of precision medicines for molecularly defined patient populations and situates its work within a global oncology research ecosystem.